InMed Pharmaceuticals Inc
Research InMed Pharmaceuticals Inc (INM) on Bullrun: market cap USD 5.20M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINM
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 5.20M
- Financial periodFY2025
- RevenueUSD 4.94M
- Revenue growth7.5%
- Net income-USD 8.16M
- Gross margin34.5%
Valuation Snapshot
latest market cap is USD 5.20M.
About InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.
Frequently asked questions
What is InMed Pharmaceuticals Inc's market cap?
InMed Pharmaceuticals Inc's market capitalization is USD 5.20M.
What does InMed Pharmaceuticals Inc do?
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial.